GGrantIndex
← Leaderboards

Dennis G. Moledina

Yale University

$4,592,286
Attributed
$5,330,196
Total exposure
3
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.3M · FY201825
$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$5,330,196 · 3

By mechanism

R01$4,410,686 · 2
K23$919,510 · 1

Top collaborators

Most similar at Yale University

Same institution · by research overlap

Others in their field

Other Emerging Leaders on “Cohort

Research focus

CohortClinical TrialsKidneyPharmaceutical PreparationsEnrollmentUrineInflammationInterstitial NephritisPatient CareFuturePlasmaRenal FunctionTherapeutic ImmunosuppressionDiagnostic BiomarkerAcuteHistologicDiagnosisBiobankBiological MarkersParticipantRenal DamageKidney BiopsyDiagnostic TestsImage

Grant awards (12)

Rapid Diagnosis and Treatment Response Phenotyping of Immune Checkpoint Inhibitor-Associated Acute Interstitial Nephritis$719,851
R01 · FY2025 · DK · contact PI
Biomarkers for acute interstitial nephritis in humans$532,801
R01 · FY2025 · DK · contact PI
Rapid Diagnosis and Treatment Response Phenotyping of Immune Checkpoint Inhibitor-Associated Acute Interstitial Nephritis$755,970
R01 · FY2024 · DK · contact PI
Biomarkers for acute interstitial nephritis in humans$552,936
R01 · FY2024 · DK · contact PI
Biomarkers for acute interstitial nephritis in humans$606,218
R01 · FY2023 · DK · contact PI
Biomarkers for acute interstitial nephritis in humans$610,901
R01 · FY2022 · DK · contact PI
Identification of Non-Invasive Biomarkers and Indices for Diagnosis of Drug-Induced Acute Interstitial Nephritis$183,097
K23 · FY2022 · DK · contact PI
Biomarkers for acute interstitial nephritis in humans$632,009
R01 · FY2021 · DK · contact PI
Identification of Non-Invasive Biomarkers and Indices for Diagnosis of Drug-Induced Acute Interstitial Nephritis$184,023
K23 · FY2021 · DK · contact PI
Identification of Non-Invasive Biomarkers and Indices for Diagnosis of Drug-Induced Acute Interstitial Nephritis$182,940
K23 · FY2020 · DK · contact PI
Identification of Non-Invasive Biomarkers and Indices for Diagnosis of Drug-Induced Acute Interstitial Nephritis$183,637
K23 · FY2019 · DK · contact PI
Identification of Non-Invasive Biomarkers and Indices for Diagnosis of Drug-Induced Acute Interstitial Nephritis$185,813
K23 · FY2018 · DK · contact PI